Exagen Inc. (XGN): who owns it and who trades it
As of Nov 16, 2026, XGN insiders reported 8 open-market sales worth $1.3M and 4 purchases worth $569K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Jorey Chernett (10% owner), with $815K. 4 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Exagen
From the latest filingsOverall: about as much buying as selling. Funds and insiders mostly sold. Famous investors mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns XGN
57 funds and institutions reported XGN shares worth $38.4M at the end of Q2 2026, about 34% of the company. The largest holder is Wexford Capital LP with 3.3%.
Funds and institutions (13F) 34%Everyone else 66%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Wexford Capital LP | 792,855 | 3.30% | $3.7M | No change |
| Nano Cap New Millennium Growth Fund L P | 675,000 | 2.81% | $3.1M | +15% |
| First Eagle Investment Management, LLC | 613,930 | 2.55% | $2.9M | +390% |
| Vanguard Capital Management LLC | 612,832 | 2.55% | $2.8M | -10% |
| FourWorld Capital Management LLC | 596,528 | 2.48% | $2.8M | +36% |
| Silvercrest Asset Management Group LLC | 514,761 | 2.14% | $2.4M | -4% |
| Kennedy Capital Management LLC | 485,048 | 2.02% | $2.3M | -2% |
| Mink Brook Asset Management LLC | 475,944 | 1.98% | $2.2M | +29% |
| Jane Street Group, LLC | 322,502 | 1.34% | $1.5M | +36% |
| Acadian Asset Management LLC | 310,084 | 1.29% | $1.4M | -55% |
| Marshall Wace, LLP | 306,703 | 1.28% | $1.4M | +1024% |
| Flputnam Investment Management Co | 288,810 | 1.20% | $1.3M | New |
| Gsa Capital Partners LLP | 214,721 | 0.89% | $998K | -15% |
| Rtw Investments, LP | 195,000 | 0.81% | $907K | -51% |
| Geode Capital Management, LLC | 185,654 | 0.77% | $864K | +4% |
| Man Group plc | 167,292 | 0.70% | $778K | +29% |
| BlackRock, Inc. | 142,625 | 0.59% | $663K | +13% |
| Perceptive Advisors LLC | 114,893 | 0.48% | $534K | No change |
| XTX Topco Ltd | 111,948 | 0.47% | $521K | -54% |
| Sei Investments Co | 109,005 | 0.45% | $507K | -55% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, XGN insiders reported $569K of open-market purchases and $1.3M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | Jorey Chernett | 10% owner | Sale | 58,068 | $4.08 | $237K | Form 4 |
| Nov 12, 2026 | Jorey Chernett | 10% owner | Sale | 109,436 | $4.65 | $509K | Form 4 |
| Nov 11, 2026 | Jorey Chernett | 10% owner | Purchase | 71,315 | $5.23 | $373K | Form 4 |
| Nov 10, 2026 | Jorey Chernett | 10% owner | Purchase | 7,085 | $5.26 | $37.3K | Form 4 |
| Nov 9, 2026 | Jorey Chernett | 10% owner | Purchase | 8,500 | $6.35 | $54K | Form 4 |
| Nov 6, 2026 | Jorey Chernett | 10% owner | Sale | 11,265 | $6.14 | $69.2K | Form 4 |
| Oct 19, 2026 | Jorey Chernett | 10% owner | Purchase | 14,000 | $7.46 | $104K | Form 4 |
| Oct 16, 2026 | John Aballi | CEO | Sale | 34,294 | $7.87 | $270K | Form 4 |
| Sep 1, 2026 | Jeffrey G. Black | CFO | Sale | 20,614 | $7.22 | $149K | Form 4 |
| Mar 3, 2026 | John Aballi | CEO | Sale | 15,698 | $3.62 | $56.8K | Form 4 |
| Feb 24, 2026 | John Aballi | CEO | Sale | 11,430 | $3.61 | $41.3K | Form 4 |
| Feb 24, 2026 | Jeffrey G. Black | CFO | Sale | 1,584 | $3.61 | $5.7K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Jorey Chernett | 10% owner | $569K | $815K | Nov 13, 2026 |
| John Aballi | President and CEO, Director | – | $368K | Oct 16, 2026 |
| Jeffrey G. Black | Chief Financial Officer | – | $155K | Sep 1, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
XGN short interest
Low short interest. 3.0% of XGN shares are sold short: about 1 share in 33. Over the last 12 reports the number of shares short went up 2%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 727,455 XGN shares were sold short, 3.0% of the shares outstanding, up 8.0% from the report before. At the average daily volume of 366,878 shares, buying them all back would take about 2.0 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 727,455 | 3.00% | +8% | 366,878 | 2.0 |
| Oct 15, 2026 | 673,850 | 2.78% | -4% | 370,013 | 1.8 |
| Sep 30, 2026 | 704,634 | 2.91% | -12% | 286,372 | 2.5 |
| Sep 15, 2026 | 800,344 | 3.30% | -7% | 223,196 | 3.6 |
| Aug 31, 2026 | 864,038 | 3.57% | -8% | 339,503 | 2.5 |
| Aug 14, 2026 | 940,432 | 3.88% | +4% | 625,582 | 1.5 |
| Jul 31, 2026 | 903,876 | 3.73% | -8% | 216,667 | 4.2 |
| Jul 15, 2026 | 978,980 | 4.07% | +20% | 218,562 | 4.5 |
| Jun 30, 2026 | 813,368 | 3.38% | +28% | 238,208 | 3.4 |
| Jun 15, 2026 | 633,365 | 2.63% | -27% | 339,817 | 1.9 |
| May 29, 2026 | 864,742 | 3.60% | +21% | 472,052 | 1.8 |
| May 15, 2026 | 716,154 | 2.98% | -1% | 854,143 | 1.0 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Exagen company events
Exagen filed 7 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 10, 2026.
- Nov 10, 2026ResultsReleased financial results. Filing
- Aug 4, 2026ResultsReleased financial results. Filing
- Jun 9, 2026VoteReported shareholder vote results. Filing
- May 11, 2026ResultsReleased financial results. Filing
- Apr 23, 2026LeadershipAna Hooker notified the Board of Directors of Exagen Inc. of her decision to resign as member of the Board, including all committees thereof, effective April 17, 2026. Filing
- Mar 10, 2026ResultsReleased financial results. Filing
- Jan 12, 2026AnnouncementThe following information contained in the Press Release is deemed “filed” for purposes of Section 18 of the Exchange Act and deemed incorporated by reference into this Item 8.01: • The information included under the headings “Select Preliminary Unaudited 2025 Results,” “Cautionary Note Regarding… Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Exagen financials
Famous investors that hold XGN
4 of the 50 well-known investors we track reported holding XGN in their latest 13F filing. The largest position is Ken Griffin's, worth $2.2M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 273,804 | $2.2M | 0.0% | +1802% |
| Israel Englander · Millennium Management | Q3 2026 | 127,817 | $1M | 0.0% | New |
| Jim Simons · Renaissance Technologies | Q3 2026 | 59,382 | $483K | 0.0% | +50% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 16,267 | $132K | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named XGN in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 13, 2026 | Chernett Jorey | 13G/A | 3.5% |
| Nov 13, 2026 | NMSIC Co-Investment Fund, L.P. | 13G/A | 3.4% |
| Nov 13, 2026 | Chernett Jorey | 13G/A | 3.5% |
| Nov 13, 2026 | NMSIC Co-Investment Fund, L.P. | 13G/A | 3.4% |
Questions about Exagen Inc. (XGN) stock
Who owns the most XGN stock?
The largest reported owner of Exagen Inc. (XGN) is Wexford Capital LP, with 3.3% of the company. In total, 57 funds and institutions reported holding XGN at the end of Q2 2026, together about 34% of the shares. See the largest owners.
Are XGN insiders buying or selling?
In the last 12 months, XGN insiders reported 4 open-market purchases worth $569K and 8 sales worth $1.3M. The latest trade was on Nov 13, 2026. See every trade.
What is the short interest in XGN?
As of Oct 30, 2026, 727,455 XGN shares were sold short, 3.0% of the shares outstanding, up 8.0% from the report before. At the average daily volume of 366,878 shares, buying them all back would take about 2.0 trading days (days to cover). See the history.
Which famous investors hold XGN?
4 of the 50 well-known investors we track reported XGN in their latest 13F filing, including Ken Griffin, Israel Englander, Jim Simons. The largest position is worth $2.2M. See all holders.
Executive pay
Exagen's chief executive was paid a total of $1.4M for the year ended Dec 31, 2025, up 18% from $1.2M the year before. In the last 12 months, Exagen's executives and directors bought no stock on the open market and sold $522K.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.